PharmExec Blog
Follow Us
RSS
Bookstore
Category Archives: News
GE Capital CFO Survey Reveals State of Pharma Industry in 2010, 2011
Industry CFOs are driving much of the current strategy of big pharma, which is to push costs of administration and selling down to compensate for low rates of organic growth through new product introductions. This survey of their views is timely and important in gauging the direction of pharma strategy in the next year.
Last week, GE [...]
Merck Gets to the Heart of the Matter
Merck may have succeeded in making a molecule that increases “good cholesterol,” which is likely the only real breakthrough left in the anti-cholesterol and hypertension market.
It has long been known that elevated LDL cholesterol and reduced HDL cholesterol are major risk factors for developing cardiovascular disease. And while much ado has been made about a [...]
Understanding Serious Adverse Events Takes Serious Cooperation
What if the technology is at hand to prevent adverse reactions to medicines before they start?
The International Serious Adverse Events Consortium (iSAEC) came together in 2007 to research the cause of certain drug-induced serious adverse reactions, posing the question, “What if the identification of risk for adverse events were not a random development, but instead [...]
Financial Woes Affect Cancer Patients’ Treatment Decisions
A recent survey conducted by MDLinx reveals that 95 percent of the nation’s oncologists report a rise in their patients’ concerns over treatment costs in the past six months.
Of the 106 US oncologists surveyed in a MDLinx survey last month, 84 percent said they had invested more time and effort into the financial planning of [...]
A Closer Look at ProPublica